In response to the ongoing global AIDS crisis, which saw 39 million infections and 630,000 deaths in 2022 alone, the Government Pharmaceutical Organization (GPO) of Thailand is intensifying its efforts in the production and research of antiviral drugs. With the aim of ensuring patients receive proper treatment, GPO’s initiative is a critical step toward curbing the epidemic. 

Dr. Nanthakarn Suwanpitakkul Deputy Director at Thai GPO has reported worrying statistics: as of April 27, 2023, Thailand has recorded 560,000 living with the infection, with an average of 25 new cases per day, and an annual death toll of approximately 11,000. Alarmingly, nearly half of the new infections are among young people aged 15-24 years. 

 

 

In an effort to provide patients with better treatment options and improve their quality of life, the GPO is dedicated to the development of new drug groups that adhere to the latest treatment guidelines. This includes innovative approaches such as dual-drug combinations instead of the traditional three-drug regimen, which aim to simplify medication routines, reduce side effects, and maintain or enhance the effectiveness of the treatment. This strategy also supports patient adherence to medication schedules and mitigates drug resistance. 

The GPO has made significant strides in developing antiviral drugs formulated with Dolutegravir, as well as medication to manage complications like anti-hepatitis B drugs that minimize drug resistance. The broad-spectrum antiviral drugs for hepatitis are also in the GPO’s pipeline. Several of these drugs have already been registered with the Thai Food and Drug Administration (Thai FDA) and have been progressively made available to patients since the beginning of 2020, with further releases planned through 2024. 

 

Committed to ongoing research and development, the GPO is not only working on new treatments but also seeking to make them more affordable. By reducing drug prices, the organization aims to expand access to these vital medications, promoting better health outcomes for those affected. The quick identification of AIDS and timely treatment are pivotal, as the GPO plays a crucial role in the national mission to end the AIDS epidemic. By fostering awareness and prevention, especially among the youth, and encouraging community support, the GPO contributes to Thailand’s goal of ending AIDS by 2030.